AAAAAA

   
Results: 1-9 |
Results: 9
Platelet glycoprotein IIb/IIIa blockade in acute ischemic stroke
Authors: Bogousslavsky, J Leclerc, JR
Citation: J. Bogousslavsky et Jr. Leclerc, Platelet glycoprotein IIb/IIIa blockade in acute ischemic stroke, CEREB DIS, 11(4), 2001, pp. 287-293
A randomized management study of impedance plethysmography vs. contrast venography in patients with a first episode of clinically suspected deep veinthrombosis
Authors: Kahn, SR Joseph, L Grover, SA Leclerc, JR
Citation: Sr. Kahn et al., A randomized management study of impedance plethysmography vs. contrast venography in patients with a first episode of clinically suspected deep veinthrombosis, THROMB RES, 102(1), 2001, pp. 15-24
Hematology-neurology connection: Association between factor XIII and hemorrhagic stroke in young women through genetic polymorphism
Authors: Leclerc, JR
Citation: Jr. Leclerc, Hematology-neurology connection: Association between factor XIII and hemorrhagic stroke in young women through genetic polymorphism, STROKE, 32(11), 2001, pp. 2586-2587
Platelet glycoprotein IIb/IIIa antagonists for acute ischemic stroke
Authors: Bogousslavsky, J Leclerc, JR
Citation: J. Bogousslavsky et Jr. Leclerc, Platelet glycoprotein IIb/IIIa antagonists for acute ischemic stroke, NEUROLOGY, 57(5), 2001, pp. S53-S57
Hemostatic markers in patients at risk of cerebral ischemia
Authors: Cote, R Wolfson, C Solymoss, S Mackey, A Leclerc, JR Simard, D Rouah, F Bourque, F Leger, B
Citation: R. Cote et al., Hemostatic markers in patients at risk of cerebral ischemia, STROKE, 31(8), 2000, pp. 1856-1862
Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study
Authors: Adams, HP Bogousslavsky, J Barnathan, E Brott, T Fisher, M Furlan, AJ Graffagnino, C Kappelle, J Kothari, R Leclerc, JR Moulin, T Polzer, J Torner, J Worley, S Haley, CE Day, JH Levine, SR Thompson, JLP Sherman, DG Sane, DC Maley, JE Grimsman, KJ Maeder, M Clarke, WR Anderson, K Cook, R FitzPatrick, S Peeters, A Cras, P Blecic, S Laloux, P Chatel, M Mahagne, H Moulin, T Hacke, W Diener, HC Bogousslavsky, J Maeder, M Kappelle, LJ Vermulen, M Kwa, VIH Franke, CL Jacoby, M Libman, R Hsu, C Kothari, R Raps, EC Kasner, SE Scott, P Karanjia, P Heiselman, D Graffagnino, C Graham, G Akins, PT Brott, T Meschia, J Furlan, AJ Gordon, D Jackson, CM Starkman, S Wityk, R Worley, S Adams, HP Belden, JR Dashe, J Fisher, M Gomez, C Hwang, TL Jichici, D Thompson, D Adams, HP Barnathan, E Bogousslavsky, J Brott, T Fisher, M Furlan, AJ Hacke, W Kappelle, J Kothari, R Leclerc, JR Moulin, T Polzer, J Scott, P Torner, J
Citation: Hp. Adams et al., Abciximab in acute ischemic stroke - A randomized, double-blind, placebo-controlled, dose-escalation study, STROKE, 31(3), 2000, pp. 601-609
Platelet glycoprotein IIb/IIIa antagonists in ischemic cerebrovascular disease
Authors: Leclerc, JR Mascelli, MA Weisman, HF
Citation: Jr. Leclerc et al., Platelet glycoprotein IIb/IIIa antagonists in ischemic cerebrovascular disease, CORON ART D, 10(8), 1999, pp. 575-579
Strategies for the prevention of pulmonary embolus for patients at risk during surgical operations and also in the medical environment.
Authors: Leclerc, JR
Citation: Jr. Leclerc, Strategies for the prevention of pulmonary embolus for patients at risk during surgical operations and also in the medical environment., REV MAL RES, 16(5BIS), 1999, pp. 939-948
Clinical prediction of deep vein thrombosis in patients with leg symptoms
Authors: Kahn, SR Joseph, L Abenhaim, L Leclerc, JR
Citation: Sr. Kahn et al., Clinical prediction of deep vein thrombosis in patients with leg symptoms, THROMB HAEM, 81(3), 1999, pp. 353-357
Risultati: 1-9 |